Two diabetes drugs could become more affordable for Maryland residents, following a study by the Prescription Drug ...

AstraZeneca CFO Aradhana Sarin tells Yahoo Finance the company sees US innovation threatened by China, even as it commits $50 billion in manufacturing.

Speaking from Astra's offices in New York, Sir Pascal Soriot (pictured) said it was 'global', but it was 'very much rooted ...

Aspiration is terrific, but Labour's bravado about Britain being the fastest growing economy in the G7 was always hooey.

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

With its latest $50 billion U.S. manufacturing investment and record U.S. growth, is British AstraZeneca looking at itself as ...

The FTSE 100 concluded the day with a 0.6% increase, driven by healthcare gains and AstraZeneca's strong profit report.

A formal trade agreement between the US and EU introduces a 15% tariff on most EU exports, including pharmaceuticals, ...

Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...

AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 ...

AstraZeneca adjusts its U.S. strategy by proposing drug price cuts and expanding local production in response to pressure ...

AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...